The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure
- PMID: 33478648
- DOI: 10.1016/j.jacc.2020.11.029
The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure
Keywords: LV remodeling; SGLT2 inhibitors; cardiac magnetic resonance; clinical trial; heart failure.
Conflict of interest statement
Author Disclosures Dr. Goldberg has received research grants and consulting fees from Respircardia; and has received consulting fees from Abbott.
Comment on
-
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.J Am Coll Cardiol. 2021 Jan 26;77(3):243-255. doi: 10.1016/j.jacc.2020.11.008. Epub 2020 Nov 13. J Am Coll Cardiol. 2021. PMID: 33197559 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical